Financing HIV/AIDS programs in sub-Saharan Africa.
This paper offers an analysis of the costs and the financing of HIV/AIDS programs for countries in sub-Saharan Africa. The rate of external financing varies with gross domestic product (GDP) per capita, but not much at all with HIV prevalence. In six of the thirty-four countries examined, the costs of HIV/AIDS programs will exceed 3 percent of GDP by 2015. Most of these are low-income countries. Considerable external support at current rates in these countries would help contain the fiscal costs to around 1 percent of GDP. But if that support dwindles, countries would have to borrow money or cut back on their own spending for HIV/AIDS.
Haacker
Markus
M
Health Policy Unit, London School of Hygiene and Tropical Medicine, London, England. markus.haacker@lshtm.ac.uk
D000163:Acquired Immunodeficiency Syndrome / Q000191:economics / Q000517:prevention & control; D017954:Africa South of the Sahara / Q000453:epidemiology; D015658:HIV Infections / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control; D017048:Health Care Costs / Q000706:statistics & numerical data* / Q000639:trends; D005102:Health Expenditures / Q000706:statistics & numerical data / Q000639:trends; D006801:Humans; D015995:Prevalence